|
94
|
263
|
1nq0A |
Tr receptor mutations conferring hormone resistance and reduced corepressor release exhibit decreased stability in the nterminal lbd |
|
84
|
260
|
1nuoA |
Two rth mutants with impaired hormone binding |
|
90
|
263
|
1nq1A |
Tr receptor mutations conferring hormone resistance and reduced corepressor release exhibit decreased stability in the nterminal lbd |
|
98
|
244
|
1nq7A |
Characterization of ligands for the orphan nuclear receptor rorbeta |
|
105
|
292
|
1nrlA |
Crystal structure of the human pxr-lbd in complex with an src-1 coactivator peptide and sr12813 |
|
95
|
275
|
1nyxA |
Ligand binding domain of the human peroxisome proliferator activated receptor gamma in complex with an agonist |
|
104
|
263
|
1navA |
Thyroid receptor alpha in complex with an agonist selective for thyroid receptor beta1 |
|
71
|
240
|
1ndeA |
Estrogen receptor beta with selective triazine modulator |
|
100
|
251
|
1n83A |
Crystal structure of the complex between the orphan nuclear hormone receptor ror(alpha)-lbd and cholesterol |
|
89
|
250
|
1naxA |
Thyroid receptor beta1 in complex with a beta-selective ligand |
|
86
|
247
|
1nhzA |
Crystal structure of the antagonist form of glucocorticoid receptor |
|
86
|
263
|
1nq2A |
Two rth mutants with impaired hormone binding |
|
83
|
232
|
1mv9A |
Crystal structure of the human rxr alpha ligand binding domain bound to the eicosanoid dha (docosa hexaenoic acid) and a coactivator peptide |
|
83
|
230
|
1mvcA |
Crystal structure of the human rxr alpha ligand binding domain bound to the synthetic agonist compound bms 649 and a coactivator peptide |
|
82
|
232
|
1mznA |
Crystal structure at 1.9 angstroems resolution of the homodimer of human rxr alpha ligand binding domain bound to the synthetic agonist compound bms 649 and a coactivator peptide |
|
98
|
244
|
1n4hA |
Characterization of ligands for the orphan nuclear receptor rorbeta |
|
93
|
251
|
1n46A |
Crystal structure of human tr beta ligand-binding domain complexed with a potent subtype-selective thyromimetic |
|
81
|
229
|
1lv2A |
Hepatocyte nuclear factor 4 is a transcription factor that constitutively binds fatty acids |
|
97
|
293
|
1m13A |
Crystal structure of the human pregane x receptor ligand binding domain in complex with hyperforin, a constituent of st. john's wort |
|
90
|
255
|
1m2zA |
Crystal structure of a dimer complex of the human glucocorticoid receptor ligand-binding domain bound to dexamethasone and a tif2 coactivator motif |
|
75
|
226
|
1m7wA |
Hnf4a ligand binding domain with bound fatty acid |
|
86
|
222
|
1kv6A |
X-ray structure of the orphan nuclear receptor err3 ligand-binding domain in the constitutively active conformation |
|
91
|
243
|
1l2iA |
Human estrogen receptor alpha ligand-binding domain in complex with (r,r)-5,11-cis-diethyl-5,6,11,12-tetrahydrochrysene-2,8-diol and a glucocorticoid receptor interacting protein 1 nr box ii peptide |
|
80
|
241
|
1l2jA |
Human estrogen receptor beta ligand-binding domain in complex with (r,r)-5,11-cis-diethyl-5,6,11,12-tetrahydrochrysene-2,8-diol |
|
81
|
269
|
1kkqA |
Crystal structure of the human ppar-alpha ligand-binding domain in complex with an antagonist gw6471 and a smrt corepressor motif |
|
101
|
273
|
1knuA |
Ligand binding domain of the human peroxisome proliferator activated receptor gamma in complex with a synthetic agonist |
|
74
|
232
|
1k74A |
The 2.3 angstrom resolution crystal structure of the heterodimer of the human ppargamma and rxralpha ligand binding domains respectively bound with gw409544 and 9-cis retinoic acid and co-activator peptides. |
|
97
|
244
|
1k4wA |
X-ray structure of the orphan nuclear receptor ror beta ligand-binding domain in the active conformation |
|
98
|
272
|
1k74D |
The 2.3 angstrom resolution crystal structure of the heterodimer of the human ppargamma and rxralpha ligand binding domains respectively bound with gw409544 and 9-cis retinoic acid and co-activator peptides. |
|
91
|
267
|
1k7lA |
The 2.5 angstrom resolution crystal structure of the human pparalpha ligand binding domain bound with gw409544 and a co-activator peptide. |
|
91
|
246
|
1i37A |
Crystal structure of the rat androgen receptor ligand binding domain complex with dihydrotestosterone |
|
102
|
255
|
1ie9A |
Crystal structure of the nuclear receptor for vitamin d ligand binding domain bound to mc1288 |
|
98
|
270
|
1i7gA |
Crystal structure of the ligand binding domain from human ppar-alpha in complex with the agonist az 242 |
|
101
|
253
|
1ie8A |
Crystal structure of the nuclear receptor for vitamin d ligand binding domain bound to kh1060 |
|
96
|
270
|
1i7iA |
Crystal structure of the ligand binding domain of human ppar-gamma in complex with the agonist az 242 |
|
89
|
247
|
1i38A |
Crystal structure of the rat androgen receptor ligand binding domain t877a mutant complex with dihydrotestosterone |
|
81
|
218
|
1hj1A |
Rat oestrogen receptor beta ligand-binding domain in complex with pure antioestrogen ici164,384 |
|
90
|
265
|
1hg4A |
Ultraspiracle ligand binding domain from drosophila melanogaster |
|
91
|
270
|
1gwxA |
Molecular recognition of fatty acids by peroxisome proliferator-activated receptors |
|
96
|
248
|
1gwqA |
Human oestrogen receptor alpha ligand-binding domain in complex with raloxifene core and tif2 nrbox2 peptide |
|
81
|
224
|
1h9uA |
The structure of the human retinoid-x-receptor beta ligand binding domain in complex with the specific synthetic agonist lg100268 |
|
98
|
244
|
1gwrA |
Human oestrogen receptor alpha ligand-binding domain in complex with 17beta-oestradiol and tif2 nrbox3 peptide |
|
98
|
248
|
1gs4A |
Structural basis for the glucocorticoid response in a mutant human androgen receptor (arccr) derived from an androgen-independent prostate cancer |
|
100
|
272
|
1fm6D |
The 2.1 angstrom resolution crystal structure of the heterodimer of the human rxralpha and ppargamma ligand binding domains respectively bound with 9-cis retinoic acid and rosiglitazone and co-activator peptides. |
|
77
|
228
|
1g1uA |
The 2.5 angstrom resolution crystal structure of the rxralpha ligand binding domain in tetramer in the absence of ligand |
|
87
|
247
|
1g50A |
Crystal structure of a wild type her alpha lbd at 2.9 angstrom resolution |
|
75
|
232
|
1fm6A |
The 2.1 angstrom resolution crystal structure of the heterodimer of the human rxralpha and ppargamma ligand binding domains respectively bound with 9-cis retinoic acid and rosiglitazone and co-activator peptides. |
|
99
|
272
|
1fm9D |
The 2.1 angstrom resolution crystal structure of the heterodimer of the human rxralpha and ppargamma ligand binding domains respectively bound with 9-cis retinoic acid and gi262570 and co-activator peptides. |
|
92
|
256
|
1g2nA |
Crystal structure of the ligand binding domain of the ultraspiracle protein usp, the ortholog of rxrs in insects |
|
76
|
228
|
1g5yA |
The 2.0 angstrom resolution crystal structure of the rxralpha ligand binding domain tetramer in the presence of a non-activating retinoic acid isomer. |
